Free Trial

AstraZeneca (AZNCF) News Today

AstraZeneca logo
$140.10 -3.30 (-2.30%)
As of 11:14 AM Eastern
AstraZeneca to invest $2.5bn in R&D centre in China
AstraZeneca and Alteogen agree on ALT-B4 platform tech
AstraZeneca to acquire EsoBiotec for $425M upfront
AstraZeneca: A Big Pharma Blue Chip To Buy Now
FibroGen sells China unit to AstraZeneca for $160m
FDA posts observations from AstraZeneca site inspection
Bernstein Reaffirms Their Buy Rating on AstraZeneca (AZN)
AstraZeneca: IMFINZI improved event-free survival, OS across MIBC
AstraZeneca upgraded to Buy from Neutral at UBS
AstraZeneca (AZN) Receives a Hold from DZ BANK AG
AstraZeneca (AZN) Gets a Hold from Deutsche Bank
AstraZeneca reports Q4 core EPS $2.09, up 49% at CER
4AZN : AstraZeneca Unusual Options Activity
AstraZeneca’s Imfinzi recommended for approval in EU by CHMP
Remove Ads
Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter.

AZNCF Media Mentions By Week

AZNCF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AZNCF
News Sentiment

0.19

0.78

Average
Medical
News Sentiment

AZNCF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AZNCF Articles
This Week

6

6

AZNCF Articles
Average Week

Remove Ads
Get AstraZeneca News Delivered to You Automatically

Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTCMKTS:AZNCF) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners